샘플 요청 목록

 카트 문의
시장보고서
상품코드
1495913

세계의 분만후 출혈(PPH) 치료 기기 시장

Postpartum Hemorrhage (PPH) Treatment Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 207 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

분만후 출혈(PPH) 치료 기기 세계 시장은 2030년까지 11억 달러에 달할 전망

2023년에 7억 8,930만 달러로 추정되는 분만후 출혈(PPH) 치료 기기 세계 시장은 분석기간 2023-2030년에 CAGR 4%로 성장하고, 2030년에는 11억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 자궁 풍선 탐포네이드는 CAGR 3.7%를 기록하고, 분석기간 종료까지 5억 590만 달러에 달할 것으로 예측됩니다. 비공기식 안티쇼크 가먼트(NASG) 분야의 성장은 향후 8년간 CAGR이 4%로 추정됩니다.

미국 시장은 2억 7,860만 달러, 중국은 CAGR 5.4%로 성장 예측

미국의 분만후 출혈(PPH) 치료 기기 시장은 2023년에는 2억 7,860만 달러에 달할 것으로 추정됩니다. 세계 2위 경제 대국인 중국은 2023년부터 2030년까지 분석기간 동안 CAGR 5.4%로 성장하여 2030년에는 1억 4,680만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있고, 각각 2023년부터 2030년까지 2.8%와 4%의 성장이 예측됩니다. 유럽에서는 독일이 CAGR 약 3.3%로 성장할 것으로 예측됩니다. 호주, 인도, 한국 등의 국가가 견인하는 아시아태평양 시장은 2030년까지 9,030만 달러에 달할 것으로 예측됩니다.

2024년 매력적인 새로운 보고서 기능 소개

인플루언서 참여 통계에 대한 풀 액세스

디지털 아카이브와 "MarketGlass" 조사 플랫폼에 무료로 액세스할 수 있습니다. 당사의 독자적인 MarketGlass 플랫폼은 전 세계 전문가들의 창의성과 시장 지식을 통합적이고 협력적으로 발휘할 수 있도록 지원합니다. 당사의 최첨단 도구는 시장 진입자의 프라이버시와 신원을 보호하면서 세계적 수준의 시장 전망을 제공합니다. 보고서의 수치, 통계 및 시장 설명은 이 분야의 전문가와 영향력 있는 사람들이 공유한 완전히 선별된 인사이트를 기반으로 합니다.

실시간 데이터 시뮬레이터 도구와 맞춤형 보고서 작성 기능을 갖춘 인터랙티브 설문 조사에 참여할 수 있습니다.

기업 간 스마트한 의견 교환을 위한 피어 협업 인터랙티브 플랫폼에 대한 풀 클라이언트 액세스

1년간 무료 보고서 업데이트

주요 기업의 세계 시장 점유율을 포함한 경쟁 커버리지

여러 지역에 걸친 기업의 시장 입지 분석(호조/활발/틈새/마이너)

전문가/인플루언서 인터뷰, 팟캐스트, 언론 발표, 이벤트 기조연설 유튜브 동영상에 대한 접근성

2024년 세계 경제에 대한 기대

통화 긴축과 이에 따른 금리 상승으로 인한 지정학적, 경제적 불안정성이 2024년 격동적인 상황을 만들어 낼 것으로 보입니다. 중동의 적대 행위와 점점 더 잦아지는 기후 재해 등 여러 요인들이 회복의 길에 계속 압력을 가할 것으로 예상됩니다. 위험요인이 있는 반면, 디플레이션 조짐이 강해지고, 완고한 인플레이션에 대한 불안감이 완화되고, 공급망이 정상화되고, 에너지 비용 변동에도 불구하고 물가가 완만하게 상승하는 등 몇 가지 긍정적인 요인도 나타나고 있습니다. 인도와 미국을 비롯한 G21 국가들의 선거는 자본 흐름과 투자 전략에 영향을 미칠 수 있습니다. 인도가 글로벌 투자처로 주목받고 있는 가운데, 미국에 기반을 둔 하이테크 기업들은 역동적인 인재와 자본 생태계에 힘입어 계속 우위를 점할 것으로 보입니다. 실리콘밸리를 비롯한 하이테크 기회는 국내 경제가 둔화되긴 했지만 여전히 견고하고 규제 환경이 잘 정비되어 있어 높은 성장 잠재력을 추구하는 투자자들에게 여전히 매력적일 것으로 보입니다. 유럽은 긴축정책과 경기침체 리스크와의 싸움이 계속되고 있으며, 영국은 2024년 경기침체 리스크가 가장 높은 국가로 가장 어려운 전망을 보이고 있습니다. 중국은 정부 지출과 개인 소비 개선에 힘입어 성장세를 이어갈 것으로 예상되는 와일드카드가 될 것입니다. 불안정한 환경은 투자자와 기업 모두에게 기회와 도전을 동시에 가져다 줄 것으로 보입니다. 변동성을 성장의 촉매제로 받아들이고, 민첩한 투자 판단과 전략적 선견지명이 생존을 위한 핵심 요소로 작용할 것입니다.

조사 대상 기업 사례(총 26건)

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Revmedx Inc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 브라질
  • 기타 라틴아메리카
  • 중동
  • 아프리카

제4장 경쟁

KSM 24.06.21

Global Postpartum Hemorrhage (PPH) Treatment Devices Market to Reach $1.1 Billion by 2030

The global market for Postpartum Hemorrhage (PPH) Treatment Devices estimated at US$789.3 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4% over the analysis period 2023-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$505.9 Million by the end of the analysis period. Growth in the Non-Pneumatic Anti-shock Garment (NASG) segment is estimated at 4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $278.6 Million, While China is Forecast to Grow at 5.4% CAGR

The Postpartum Hemorrhage (PPH) Treatment Devices market in the U.S. is estimated at US$278.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$146.8 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$90.3 Million by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 26 Featured) -

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Revmedx Inc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Postpartum Hemorrhage - The Leading Cause of Maternal Death Globally
    • PPH: Management using PPH Treatment Devices
    • EXHIBIT 1: Global Postpartum Hemorrhage (PPH) Treatment Devices Market by Geographic Region: Annual Sales in Million Units for the Years 2023 through 2030
    • EXHIBIT 2: Global Postpartum Hemorrhage (PPH) Treatment Devices Market by Product Segment: Annual Sales in Thousand Units for the Years 2022 through 2030
    • Economic Frontiers: Trends, Trials & Transformations
    • EXHIBIT 3: In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • EXHIBIT 4: All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • EXHIBIT 5: With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
    • Competitive Landscape
    • EXHIBIT 6: Postpartum Hemorrhage (PPH) Treatment Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 26 Players Worldwide in 2024 (E)
    • Global Market Prospects and Outlook
    • Global Postpartum Hemorrhage Devices Market Sets Eyes on Pulsating Growth Ahead
    • Uterine Balloon Tamponades Lead the Global PPH Treatment Devices Market
    • US and Europe Account for Major Share of the Market
    • Developing and Developed Countries Investing More in Healthcare Industry
    • Restraining Factors for Market Growth
    • Recent Market Activity
    • Influencer/Product/Technology Insights
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Robust Scope for Device Innovations to Shoulder Burden of Mortality Reduction Goals
    • EXHIBIT 7: PPH Device R&D Pipeline: Breakdown of PPH Devices by Development Status
    • EXHIBIT 8: Current PPH Devices Ecosystem by Archetype & Clinical Use Status
    • Existing & Promising Postpartum Hemorrhage Devices
    • Balloons Command while New Options Emerge
    • Uterine balloon Tamponade PPH Devices by Archetype & Clinical Use Status
    • Widespread Use of Repurposed & Improvised PPH Devices
    • The Way Forward
    • Novel Techniques for Accurate, Timely Detection & Efficient Management of PPH
    • Timely Hemorrhage Detection
    • Fixed-Ratio Transfusion
    • Viscoelastic Hemostatic Assays
    • Approaches to Reduce Disparate Outcomes
    • Obstetricians Develop Novel Intrauterine PPH Device to Control Postpartum Bleeding
    • Increase in Birth Rate Offers Opportunities for Postpartum Hemorrhage Market
    • EXHIBIT 9: Global New Births (in Millions) per Annum by Geographic Region
    • Birth Statistics Across the World
    • Rise in Pregnancy Complications Drives Market Growth
    • Prevalence of Anaemia in Pregnant Women Bolsters Demand
    • The Millennials Reaching Child-Bearing Age Drive Healthy Market Growth
    • EXHIBIT 10: Global Millennial Population by Region (2023): Percentage Breakdown of Number of Millennials for North America, Europe, China & Japan, Latin America and Rest of World
    • EXHIBIT 11: Millennial Population as a Percentage (%) of Total Population in Developing Countries: 2023
    • Rising Working Women Population Increases the Risk of PPH
    • EXHIBIT 12: Top 10 Countries Worldwide with the Highest Proportion of Working Women in the Nation's Women Population
    • Rising Obesity Incidence Spurs the Demand for PPH Treatment Devices
    • EXHIBIT 13: Obesity Prevalence Rate (%) in Select Countries for the Years 2023 and 2030P
    • Non-Pneumatic Anti-Shock Garment Witnesses Increased Demand
    • Leading Players and Market Share
    • EXHIBIT 14: Global Non-Pneumatic Anti-Shock Garment (NASG) Market (2023): Market Share of Major Players
    • EXHIBIT 15: Reduction in Maternal Mortality Rates due to Obstetric Hemorrhage from the Use of NASG in Select Countries
    • Supply
    • Challenges and Issues
    • Uterotonics: The Lifeblood of the Bundle Approach to Manage Postpartum Hemorrhage
    • More Focus on Uterine Atony & Uterotonics
    • Uterotonics Move Forward with New Advances to Prevent Postpartum Hemorrhage
    • Device Innovations to Control PPH to Drive Market Growth
    • PATH and Sinapi Biomedical Introduce Ellavi for Combating Postpartum Hemorrhage
    • PPH Butterfly
    • Intrauterine Vacuum Device Plays a Crucial Role in Controlling Postpartum Hemorrhage Safely and Quickly
    • Tools to Detect and Treat Postpartum Hemorrhage Minimize Maternal Deaths
    • New Wearable Optical Device for Timely Detection of Postpartum Hemorrhage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Uterine Balloon Tamponade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Uniject Prefilled Injection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Market Analytics
    • TABLE 14: USA Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • JAPAN
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • CHINA
    • TABLE 23: China Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • EUROPE
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • Market Analytics
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • FRANCE
    • TABLE 32: France Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • GERMANY
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • TABLE 41: UK Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Market Analytics
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • INDIA
    • TABLE 62: India Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 80: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Latin America 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • TABLE 83: Middle East Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Middle East Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Middle East 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030
  • AFRICA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • Market Analytics
    • TABLE 86: Africa Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Africa Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Africa 16-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제